RxAssist Home
RxAssist Home Home  |  About Us  |  Contact RxAssist          
      Patient Assistance Program Center
 

 

NOVARTIS PHARMACEUTICALS CORPORATION
Patient Assistance Program

Patient assistance programs (PAPs) are programs created by drug companies, such as NOVARTIS PHARMACEUTICALS CORPORATION, to offer free or low cost drugs to individuals who are unable to pay for their medication.  These Programs may also be called indigent drug programs, charitable drug programs or medication assistance programs.  Most of the best known and most prescribed drugs can be found in these programs.  All of the major drug companies have patient assistance programs, although every company has different eligibility and application requirements.

The NOVARTIS PHARMACEUTICALS CORPORATION patient assistance program offers free medication to people who otherwise cannot afford their medications.  Patients must meet financial and other program specific criteria to be eligible for assistance.

To find out how to apply for medication assistance from the NOVARTIS PHARMACEUTICALS CORPORATION patient assistance program, visit our Patient Center and use our Database to search for the medication needed.

For a complete listing of NOVARTIS PHARMACEUTICALS CORPORATION medications available through their patient assistance programs, see below:

Alongside KESIMPTA Program

      The medications available through this program are:
     
  Kesimpta injection (ofatumumab)
  

Leqvio Service Center and Care Program

      The medications available through this program are:
     
  Leqvio (inclisiran injection)
  

Novartis Patient Assistance Foundation, Inc.

      The medications available through this program are:
     
  Adakveo (crizanlizumab-tmca)
     
  Afinitor (everolimus)
     
  Afinitor Disperz (everolimus)
     
  Beovu (brolucizumab-dbll)
     
  Coartem (artmether and lumefantrine tablets)
     
  Cosentyx (secukinumab)
     
  Entresto (sacubitril/valsartan)
     
  Gilenya (fingolimod)
     
  Ilaris (canakinumab)
     
  Jadenu Sprinkle granules (deferasirox)
     
  Jadenu Tablet (deferasirox)
     
  Kesimpta injection (ofatumumab)
     
  Kisqali (ribociclib)
     
  Kisqali Femara Co-Pack tablets (ribociclib and letrozole)
     
  Leqvio (inclisiran injection)
     
  Lutathera (lutetium Lu 177 dotatate)
     
  Mayzent (siponimod)
     
  Mekinist (trametinib)
     
  Piqray (alpelisib)
     
  Pluvicto (lutetium LU 177 vipivotide tetraxetan injection)
     
  Promacta (eltrombopag)
     
  Sandostatin LAR Depot (octreotide acetate)
     
  Scemblix tablet (asciminib tablet)
     
  Tabrecta (capmatinib)
     
  Tafinlar (dabrafenib)
     
  Tasigna (nilotinib)
     
  Tykerb (lapatinib tablets)
     
  Votrient (pazopanib)
     
  Zykadia (ceritinib)
     
  midostaurin capsule Rydapt
  

Novartis Patient Assistance Now Oncology (PANO)

      The medications available through this program are:
     
  Adakveo (crizanlizumab-tmca)
     
  Afinitor (everolimus)
     
  Exjade (deferasirox)
     
  Gleevec (imatinib mesylate)
     
  Jadenu Tablet (deferasirox)
     
  Kisqali (ribociclib)
     
  Mekinist (trametinib)
     
  Piqray (alpelisib)
     
  Promacta (eltrombopag)
     
  Rydapt (midostaurin capsule)
     
  Sandostatin LAR Depot (octreotide acetate)
     
  Scemblix tablet (asciminib tablet)
     
  Tabrecta (capmatinib)
     
  Tafinlar (dabrafenib)
     
  Tasigna (nilotinib)
     
  Tykerb (lapatinib tablets)
     
  Vijoice (alpelisib)
     
  Votrient (pazopanib)
     
  Zykadia (ceritinib)
  

Novartis Patient Support

      The medications available through this program are:
     
  Locametz (gallium Ga 68 gozetotide)
     
  Lutathera (lutetium Lu 177 dotatate)
     
  Netspot (gallium Ga 68 dotatate)
     
  Pluvicto (lutetium LU 177 vipivotide tetraxetan injection)
  

Universal Co-Pay Card

      The medications available through this program are:
     
  Adakveo (crizanlizumab-tmca)
     
  Afinitor (everolimus)
     
  Exjade (deferasirox)
     
  Gleevec (imatinib mesylate)
     
  Jadenu Sprinkle granules (deferasirox)
     
  Jadenu Tablet (deferasirox)
     
  Kisqali (ribociclib)
     
  Kisqali Femara Co-Pack tablets (ribociclib and letrozole)
     
  Mekinist (trametinib)
     
  Piqray (alpelisib)
     
  Promacta (eltrombopag)
     
  Rydapt (midostaurin capsule)
     
  Sandostatin LAR Depot (octreotide acetate)
     
  Scemblix tablet (asciminib tablet)
     
  Tabrecta (capmatinib)
     
  Tafinlar (dabrafenib)
     
  Tasigna (nilotinib)
     
  Tykerb (lapatinib tablets)
     
  Vijoice (alpelisib)
     
  Votrient (pazopanib)
     
  Zykadia (ceritinib)
  
 
This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. Neither RxAssist nor RxVantage is offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. Neither RxVantage nor RxAssist provide any warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on rxassist.org or rxvantage.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.

Copyright © 2024, RxVantage, all rights reserved.